Clinical Trials Sponsored by Celtic Pharma Development Services

Total 15 results

Celtic Pharma Development Services

Completed

Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers

Edema

United States
Celtic Pharma Development Services

Terminated

Tolerability Study of Xerecept® in Pediatric Patients

Brain Tumor | Brain Edema

United States
Celtic Pharma Development Services

Completed

Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation

Smoking

United States
Celtic Pharma Development Services
PPD

Unknown

TDT 067 Onychomycosis Study

Onychomycosis

United States
PharmaNet
Celtic Pharma Development Services

Terminated

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

Peritumoral Brain Edema | PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
Celtic Pharma Development Services
PPD

Completed

TDT 067 Open Label Multi-Dose Onychomycosis Study

Onychomycosis
Celtic Pharma Development Services
Neurobiological Technologies

Completed

XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors

Brain Tumor | Brain Edema

United States, Canada
Celtic Pharma Development Services
Neurobiological Technologies

Completed

An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies

Brain Tumor | Brain Edema

United States, Canada
Celtic Pharma Development Services
Neurobiological Technologies

Withdrawn

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Brain Tumor | Brain Edema

United States, Canada
Pharmiva AB
CPS Research; Scandinavian Development Services AB; Key2Compliance AB

Active, not recruiting

Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

Bacterial Vaginosis | Vaginal | Microbiology

Sweden, United Kingdom
U.S. Army Medical Research and Development Command
Uniformed Services University of the Health Sciences; Meiji Seika Pharma Co...

No longer available

Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria

Infection Due to Resistant Organism

United States
VA Office of Research and Development
VHA Pharmacy Benefits Management Services VA Center For Medication Safety

Completed

Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID)

Proton Pump Inhibitors

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Multisite Controlled Trial of Cocaine Vaccine (TA-CD)

Cocaine Dependence

United States
Insud Pharma
Kenya Medical Research Institute; Barcelona Institute for Global Health; European... and other collaborators

Not yet recruiting

Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness

Soil-Transmitted Helminths

Ghana, Kenya
Galmed Research and Development, Ltd.
Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS... and other collaborators

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH (Aramchol_005)

Liver Diseases | Fatty Liver | Non-Alcoholic Steatohepatitis | Liver Fibroses

United States, Chile, Israel, Italy, France, Germany, Mexico, Georgia, Lithuania, Hong Kong, Romania

Clinical Trials Sponsored by Celtic Pharma Development Services

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations